title: Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention: NICE technology appraisal guidance.
authors.affiliation: Centre for Health Technology Evaluation, National Institute for Health and Clinical Excellence, London, UK. ruaraidh.hill@nice.org.uk
authors.forename: R A
authors.initials: RA
authors.lastname: Hill
authors.forename: H
authors.initials: H
authors.lastname: Chung
authors.forename: E
authors.initials: E
authors.lastname: George
authors.forename: C
authors.initials: C
authors.lastname: Longson
authors.forename: A
authors.initials: A
authors.lastname: Stevens
mesh_terms: D054058:Acute Coronary Syndrome / Q000191:economics / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D000068799:Prasugrel Hydrochloride; D013876:Thiophenes / Q000627:therapeutic use*
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride